What Researchers Did
Researchers investigated the effect of hyperbaric oxygen treatment on immunological parameters in 10 multiple sclerosis patients.
What They Found
After 20 hyperbaric oxygen exposures, 10 MS patients showed a significant increase in total and helper T lymphocyte counts in peripheral blood. Granulocytes also exhibited an increased proportion of Fc gamma and C3b receptor-positive cells, with increased oxygen consumption. Serum IgA levels slightly increased, while cerebrospinal fluid parameters remained unchanged.
What This Means for Canadian Patients
Canadian patients with multiple sclerosis should discuss all treatment options with their healthcare providers, as hyperbaric oxygen therapy is not a widely accepted or standard treatment for MS. Current evidence suggests that established therapies are more effective for managing MS symptoms and disease progression.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Norway and published in a European journal.
Study Limitations
A significant limitation of this study is the very small sample size of only 10 patients, which restricts the generalizability of the findings.